Have any thoughts about
Seagen Inc?
Write Note

Seagen Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Seagen Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
S
Seagen Inc
F:SGT
Selling, General & Administrative
-$922.1m
CAGR 3-Years
-23%
CAGR 5-Years
-33%
CAGR 10-Years
-26%
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$13.1B
CAGR 3-Years
-3%
CAGR 5-Years
-13%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$5.6B
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$7.2B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
-18%
CAGR 10-Years
-16%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.8B
CAGR 3-Years
-25%
CAGR 5-Years
-14%
CAGR 10-Years
-22%

See Also

What is Seagen Inc's Selling, General & Administrative?
Selling, General & Administrative
-922.1m USD

Based on the financial report for Sep 30, 2023, Seagen Inc's Selling, General & Administrative amounts to -922.1m USD.

What is Seagen Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-26%

Over the last year, the Selling, General & Administrative growth was -13%. The average annual Selling, General & Administrative growth rates for Seagen Inc have been -23% over the past three years , -33% over the past five years , and -26% over the past ten years .

Back to Top